| 
Results for opthalmology. Search took 0.13 seconds.
Bausch & Lomb Acquires Rights To Recombinant Plasmin from Talecris Biotherapeutics for Ophthalmic Use
in The Biotech Weblog, on August 31, 2006
Bausch & Lomb , a manufacturer of eye care products is expanding an agreement with biotechnology firm, Talecris Biotherapeutics , to develop a recombinant plasmin .Bausch & Lomb believes r plasmin have potentials for use in developing novel therapies for ocular conditions, part...
OSI and Eyetech Merge
in The Biotech Weblog, on August 23, 2005
Image: Eyetech
OSI Pharmaceuticals, Inc. and Eyetech Pharmaceuticals, Inc. have entered into a definitive merger agreement whereby OSI has agreed to acquire Eyetech, a biopharmaceutical company that focuses on the development and commercialization of novel therapeutics to treat eye dise...